Why the study?
Does antihypertensive therapy reduce cardiovascular event risk and arterial stiffness in hypertensive subjects?
Does antihypertensive therapy reduce cardiovascular event risk and arterial stiffness in hypertensive subjects?
Answers are grounded in this paper and cite their sources.
Cardiovascular event risk reduction in hypertensive subjects is mainly associated with the normalization of systolic blood pressure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Safar et al. (2010) conducted a review in Hypertension. Antihypertensive therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: